Report : A-Z HCD items in Formulary 24/04/2025 20:19:27

[Back]

Section Status CCG Name 06.06.01 Formulary Abaloparatide  Eladynos® 13.05.03 Formulary Abrocitinib Cibinqo® 11.08.02 Formulary Aflibercept  Eylea® 04.07.04.02 Formulary Atogepant Aquipta® 10.01.03 Formulary Baricitinib Olumiant® 11.08.02 Formulary Bevacizumab 1.25mg/0.05ml intravitreal injection  11.08.02 Formulary Bevacizumab gamma Lytenava® 10.01.03 Formulary Bimekizumab  Bimzelx® 01.03 Formulary Bismuth / Metronidazole / tetracycline Pylera® 13.05.03 Formulary Brodalumab Kyntheum® 11.08.02 Formulary Brolucizumab Beovu® 13.05.03 Formulary Deucravacitinib Sotyktu 06.04.01.02 Formulary Dienogest  04.07.04.02 Formulary Eptinezumab Vyepti® 04.07.04.02 Formulary Erenumab Aimovig® 01.05.03 Formulary Etrasimod Velsipity® 11.08.02 Formulary Faricimab Vabysmo® 01.05.03 Formulary Filgotinib Jyseleca® 10.01.03 Formulary Filgotinib Jyseleca® 04.07.04.02 Formulary Fremanezumab Ajovy® 04.07.04.02 Formulary Galcanezumab Emgality® 10.01.03 Formulary Golimumab Simponi® 13.05.03 Formulary Guselkumab Tremfya® 10.01.03 Formulary Ixekizumab Taltz® 11.06 Formulary Latanoprost 50microgram/ml with Netarsudil 200microgram/ml eye drops Roclanda® 13.05.03 Formulary Lebrikizumab Ebglyss® 04.04 Formulary Pitolisant Wakix® 11.08.02 Formulary Ranibizumab 10mg/1ml injection Lucentis® 08.03.04.02 Formulary Relugolix Orgovyx® 01.05.03 Formulary Risankizumab Skyrizi® 13.05.03 Formulary Ritlecitinib Litfulo® 06.06.02 Formulary Romosozumab Evenity ® 06.05.01 Formulary Somatrogon Ngenla® 10.01.03 Formulary Tocilizumab RoActemra® 10.01.03 Formulary Tofacitinib Xeljanz® 13.05.03 Formulary Tralokinumab Adtralza® 01.05.03 Formulary Upadacitinib Rinvoq® 10.01.03 Formulary Upadacitinib Rinvoq® 13.05.03 Formulary Upadacitinib Rinvoq®

North East and North Cumbria